nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—Tamoxifen—pancreatic cancer	0.442	1	CrCtD
Toremifene—Bedaquiline—Tamoxifen—pancreatic cancer	0.0472	0.163	CrCrCtD
Toremifene—ESR1—Tamoxifen—pancreatic cancer	0.0448	0.227	CbGbCtD
Toremifene—Clomifene—Tamoxifen—pancreatic cancer	0.043	0.148	CrCrCtD
Toremifene—Ospemifene—Tamoxifen—pancreatic cancer	0.043	0.148	CrCrCtD
Toremifene—CYP1A1—Dacarbazine—pancreatic cancer	0.0247	0.125	CbGbCtD
Toremifene—Naftifine—Tamoxifen—pancreatic cancer	0.0236	0.0815	CrCrCtD
Toremifene—CYP1A1—Tamoxifen—pancreatic cancer	0.0197	0.0996	CbGbCtD
Toremifene—Loperamide—Tamoxifen—pancreatic cancer	0.019	0.0654	CrCrCtD
Toremifene—CYP1A1—Erlotinib—pancreatic cancer	0.0167	0.0847	CbGbCtD
Toremifene—Doxylamine—Tamoxifen—pancreatic cancer	0.0164	0.0565	CrCrCtD
Toremifene—Phenoxybenzamine—Tamoxifen—pancreatic cancer	0.0156	0.0537	CrCrCtD
Toremifene—Dextropropoxyphene—Tamoxifen—pancreatic cancer	0.0156	0.0537	CrCrCtD
Toremifene—Bromodiphenhydramine—Tamoxifen—pancreatic cancer	0.0139	0.0478	CrCrCtD
Toremifene—Clofedanol—Tamoxifen—pancreatic cancer	0.0113	0.0388	CrCrCtD
Toremifene—CYP1A2—Dacarbazine—pancreatic cancer	0.011	0.056	CbGbCtD
Toremifene—Orphenadrine—Tamoxifen—pancreatic cancer	0.0109	0.0376	CrCrCtD
Toremifene—Benzphetamine—Tamoxifen—pancreatic cancer	0.0109	0.0376	CrCrCtD
Toremifene—Benzyl Benzoate—Tamoxifen—pancreatic cancer	0.0101	0.0348	CrCrCtD
Toremifene—Diphenhydramine—Tamoxifen—pancreatic cancer	0.00968	0.0334	CrCrCtD
Toremifene—CYP1A2—Tamoxifen—pancreatic cancer	0.00879	0.0445	CbGbCtD
Toremifene—ABCB1—Tamoxifen—pancreatic cancer	0.00769	0.0389	CbGbCtD
Toremifene—CYP1A2—Erlotinib—pancreatic cancer	0.00747	0.0378	CbGbCtD
Toremifene—ABCB1—Gemcitabine—pancreatic cancer	0.00662	0.0335	CbGbCtD
Toremifene—ABCB1—Erlotinib—pancreatic cancer	0.00653	0.0331	CbGbCtD
Toremifene—CYP1A2—Fluorouracil—pancreatic cancer	0.00648	0.0328	CbGbCtD
Toremifene—ABCB1—Irinotecan—pancreatic cancer	0.0059	0.0299	CbGbCtD
Toremifene—CYP3A4—Tamoxifen—pancreatic cancer	0.0046	0.0233	CbGbCtD
Toremifene—ABCB1—Docetaxel—pancreatic cancer	0.00432	0.0219	CbGbCtD
Toremifene—ABCB1—Sunitinib—pancreatic cancer	0.00431	0.0218	CbGbCtD
Toremifene—CYP3A4—Erlotinib—pancreatic cancer	0.00392	0.0198	CbGbCtD
Toremifene—CYP3A4—Irinotecan—pancreatic cancer	0.00354	0.0179	CbGbCtD
Toremifene—ABCB1—Doxorubicin—pancreatic cancer	0.00322	0.0163	CbGbCtD
Toremifene—CYP3A4—Docetaxel—pancreatic cancer	0.00259	0.0131	CbGbCtD
Toremifene—CYP3A4—Sunitinib—pancreatic cancer	0.00258	0.0131	CbGbCtD
Toremifene—CYP3A4—Doxorubicin—pancreatic cancer	0.00193	0.00978	CbGbCtD
Toremifene—Alopecia—Fluorouracil—pancreatic cancer	8.96e-05	0.00149	CcSEcCtD
Toremifene—Nervous system disorder—Sunitinib—pancreatic cancer	8.95e-05	0.00149	CcSEcCtD
Toremifene—Thrombocytopenia—Sunitinib—pancreatic cancer	8.94e-05	0.00148	CcSEcCtD
Toremifene—Back pain—Irinotecan—pancreatic cancer	8.91e-05	0.00148	CcSEcCtD
Toremifene—Angina pectoris—Docetaxel—pancreatic cancer	8.91e-05	0.00148	CcSEcCtD
Toremifene—Skin disorder—Sunitinib—pancreatic cancer	8.87e-05	0.00147	CcSEcCtD
Toremifene—Anorexia—Sunitinib—pancreatic cancer	8.7e-05	0.00144	CcSEcCtD
Toremifene—Back pain—Gemcitabine—pancreatic cancer	8.68e-05	0.00144	CcSEcCtD
Toremifene—Abnormal vision—Epirubicin—pancreatic cancer	8.57e-05	0.00142	CcSEcCtD
Toremifene—Dry eye—Doxorubicin—pancreatic cancer	8.4e-05	0.00139	CcSEcCtD
Toremifene—Weight increased—Docetaxel—pancreatic cancer	8.32e-05	0.00138	CcSEcCtD
Toremifene—Vision blurred—Fluorouracil—pancreatic cancer	8.32e-05	0.00138	CcSEcCtD
Toremifene—Vertigo—Irinotecan—pancreatic cancer	8.28e-05	0.00137	CcSEcCtD
Toremifene—Insomnia—Sunitinib—pancreatic cancer	8.26e-05	0.00137	CcSEcCtD
Toremifene—Leukopenia—Irinotecan—pancreatic cancer	8.25e-05	0.00137	CcSEcCtD
Toremifene—Thrombophlebitis—Epirubicin—pancreatic cancer	8.24e-05	0.00137	CcSEcCtD
Toremifene—Dyspnoea—Sunitinib—pancreatic cancer	8.14e-05	0.00135	CcSEcCtD
Toremifene—Acute coronary syndrome—Docetaxel—pancreatic cancer	8.04e-05	0.00133	CcSEcCtD
Toremifene—Leukopenia—Gemcitabine—pancreatic cancer	8.04e-05	0.00133	CcSEcCtD
Toremifene—Myocardial infarction—Docetaxel—pancreatic cancer	7.99e-05	0.00133	CcSEcCtD
Toremifene—Neuropathy peripheral—Docetaxel—pancreatic cancer	7.99e-05	0.00133	CcSEcCtD
Toremifene—Jaundice—Docetaxel—pancreatic cancer	7.95e-05	0.00132	CcSEcCtD
Toremifene—Decreased appetite—Sunitinib—pancreatic cancer	7.94e-05	0.00132	CcSEcCtD
Toremifene—Abnormal vision—Doxorubicin—pancreatic cancer	7.93e-05	0.00132	CcSEcCtD
Toremifene—Leukopenia—Fluorouracil—pancreatic cancer	7.9e-05	0.00131	CcSEcCtD
Toremifene—Gastrointestinal disorder—Sunitinib—pancreatic cancer	7.88e-05	0.00131	CcSEcCtD
Toremifene—Fatigue—Sunitinib—pancreatic cancer	7.87e-05	0.00131	CcSEcCtD
Toremifene—Constipation—Sunitinib—pancreatic cancer	7.81e-05	0.0013	CcSEcCtD
Toremifene—Pain—Sunitinib—pancreatic cancer	7.81e-05	0.0013	CcSEcCtD
Toremifene—Hepatobiliary disease—Docetaxel—pancreatic cancer	7.71e-05	0.00128	CcSEcCtD
Toremifene—Asthenia—Tamoxifen—pancreatic cancer	7.65e-05	0.00127	CcSEcCtD
Toremifene—Chest pain—Gemcitabine—pancreatic cancer	7.64e-05	0.00127	CcSEcCtD
Toremifene—Hot flush—Epirubicin—pancreatic cancer	7.63e-05	0.00127	CcSEcCtD
Toremifene—Thrombophlebitis—Doxorubicin—pancreatic cancer	7.63e-05	0.00127	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	7.59e-05	0.00126	CcSEcCtD
Toremifene—Asthenia—Erlotinib—pancreatic cancer	7.57e-05	0.00126	CcSEcCtD
Toremifene—Menopausal symptoms—Epirubicin—pancreatic cancer	7.56e-05	0.00126	CcSEcCtD
Toremifene—Pruritus—Tamoxifen—pancreatic cancer	7.54e-05	0.00125	CcSEcCtD
Toremifene—Oedema—Irinotecan—pancreatic cancer	7.52e-05	0.00125	CcSEcCtD
Toremifene—Chest pain—Fluorouracil—pancreatic cancer	7.51e-05	0.00125	CcSEcCtD
Toremifene—Pruritus—Erlotinib—pancreatic cancer	7.46e-05	0.00124	CcSEcCtD
Toremifene—Nervous system disorder—Irinotecan—pancreatic cancer	7.38e-05	0.00122	CcSEcCtD
Toremifene—Thrombocytopenia—Irinotecan—pancreatic cancer	7.36e-05	0.00122	CcSEcCtD
Toremifene—Oedema—Gemcitabine—pancreatic cancer	7.33e-05	0.00122	CcSEcCtD
Toremifene—Cardiac failure—Epirubicin—pancreatic cancer	7.31e-05	0.00121	CcSEcCtD
Toremifene—Lethargy—Epirubicin—pancreatic cancer	7.28e-05	0.00121	CcSEcCtD
Toremifene—Hyperhidrosis—Irinotecan—pancreatic cancer	7.27e-05	0.00121	CcSEcCtD
Toremifene—Oedema—Fluorouracil—pancreatic cancer	7.2e-05	0.0012	CcSEcCtD
Toremifene—Nervous system disorder—Gemcitabine—pancreatic cancer	7.18e-05	0.00119	CcSEcCtD
Toremifene—Thrombocytopenia—Gemcitabine—pancreatic cancer	7.17e-05	0.00119	CcSEcCtD
Toremifene—Anorexia—Irinotecan—pancreatic cancer	7.17e-05	0.00119	CcSEcCtD
Toremifene—Diplopia—Epirubicin—pancreatic cancer	7.13e-05	0.00118	CcSEcCtD
Toremifene—Skin disorder—Gemcitabine—pancreatic cancer	7.12e-05	0.00118	CcSEcCtD
Toremifene—Hyperhidrosis—Gemcitabine—pancreatic cancer	7.08e-05	0.00118	CcSEcCtD
Toremifene—Nervous system disorder—Fluorouracil—pancreatic cancer	7.06e-05	0.00117	CcSEcCtD
Toremifene—Hot flush—Doxorubicin—pancreatic cancer	7.06e-05	0.00117	CcSEcCtD
Toremifene—Thrombocytopenia—Fluorouracil—pancreatic cancer	7.05e-05	0.00117	CcSEcCtD
Toremifene—Visual impairment—Docetaxel—pancreatic cancer	7.05e-05	0.00117	CcSEcCtD
Toremifene—Dizziness—Tamoxifen—pancreatic cancer	7.05e-05	0.00117	CcSEcCtD
Toremifene—Affect lability—Epirubicin—pancreatic cancer	7.02e-05	0.00117	CcSEcCtD
Toremifene—Menopausal symptoms—Doxorubicin—pancreatic cancer	7e-05	0.00116	CcSEcCtD
Toremifene—Anorexia—Gemcitabine—pancreatic cancer	6.98e-05	0.00116	CcSEcCtD
Toremifene—Dizziness—Erlotinib—pancreatic cancer	6.97e-05	0.00116	CcSEcCtD
Toremifene—Anorexia—Fluorouracil—pancreatic cancer	6.87e-05	0.00114	CcSEcCtD
Toremifene—Eye disorder—Docetaxel—pancreatic cancer	6.84e-05	0.00114	CcSEcCtD
Toremifene—Insomnia—Irinotecan—pancreatic cancer	6.8e-05	0.00113	CcSEcCtD
Toremifene—Vomiting—Tamoxifen—pancreatic cancer	6.78e-05	0.00113	CcSEcCtD
Toremifene—Cardiac failure—Doxorubicin—pancreatic cancer	6.76e-05	0.00112	CcSEcCtD
Toremifene—Mood swings—Epirubicin—pancreatic cancer	6.76e-05	0.00112	CcSEcCtD
Toremifene—Lethargy—Doxorubicin—pancreatic cancer	6.74e-05	0.00112	CcSEcCtD
Toremifene—Rash—Tamoxifen—pancreatic cancer	6.72e-05	0.00112	CcSEcCtD
Toremifene—Dermatitis—Tamoxifen—pancreatic cancer	6.72e-05	0.00111	CcSEcCtD
Toremifene—Ataxia—Epirubicin—pancreatic cancer	6.71e-05	0.00111	CcSEcCtD
Toremifene—Vomiting—Erlotinib—pancreatic cancer	6.71e-05	0.00111	CcSEcCtD
Toremifene—Dyspnoea—Irinotecan—pancreatic cancer	6.71e-05	0.00111	CcSEcCtD
Toremifene—Headache—Tamoxifen—pancreatic cancer	6.68e-05	0.00111	CcSEcCtD
Toremifene—Rash—Erlotinib—pancreatic cancer	6.65e-05	0.0011	CcSEcCtD
Toremifene—Dermatitis—Erlotinib—pancreatic cancer	6.64e-05	0.0011	CcSEcCtD
Toremifene—Angiopathy—Docetaxel—pancreatic cancer	6.64e-05	0.0011	CcSEcCtD
Toremifene—Insomnia—Gemcitabine—pancreatic cancer	6.63e-05	0.0011	CcSEcCtD
Toremifene—Headache—Erlotinib—pancreatic cancer	6.61e-05	0.0011	CcSEcCtD
Toremifene—Diplopia—Doxorubicin—pancreatic cancer	6.6e-05	0.0011	CcSEcCtD
Toremifene—Mediastinal disorder—Docetaxel—pancreatic cancer	6.6e-05	0.00109	CcSEcCtD
Toremifene—Liver function test abnormal—Epirubicin—pancreatic cancer	6.59e-05	0.00109	CcSEcCtD
Toremifene—Chills—Docetaxel—pancreatic cancer	6.57e-05	0.00109	CcSEcCtD
Toremifene—Asthenia—Sunitinib—pancreatic cancer	6.55e-05	0.00109	CcSEcCtD
Toremifene—Decreased appetite—Irinotecan—pancreatic cancer	6.54e-05	0.00109	CcSEcCtD
Toremifene—Arrhythmia—Docetaxel—pancreatic cancer	6.54e-05	0.00109	CcSEcCtD
Toremifene—Dyspnoea—Gemcitabine—pancreatic cancer	6.53e-05	0.00108	CcSEcCtD
Toremifene—Insomnia—Fluorouracil—pancreatic cancer	6.51e-05	0.00108	CcSEcCtD
Toremifene—Affect lability—Doxorubicin—pancreatic cancer	6.5e-05	0.00108	CcSEcCtD
Toremifene—Gastrointestinal disorder—Irinotecan—pancreatic cancer	6.49e-05	0.00108	CcSEcCtD
Toremifene—Fatigue—Irinotecan—pancreatic cancer	6.48e-05	0.00108	CcSEcCtD
Toremifene—Alopecia—Docetaxel—pancreatic cancer	6.47e-05	0.00107	CcSEcCtD
Toremifene—Pruritus—Sunitinib—pancreatic cancer	6.46e-05	0.00107	CcSEcCtD
Toremifene—Breast disorder—Epirubicin—pancreatic cancer	6.45e-05	0.00107	CcSEcCtD
Toremifene—Constipation—Irinotecan—pancreatic cancer	6.43e-05	0.00107	CcSEcCtD
Toremifene—Pain—Irinotecan—pancreatic cancer	6.43e-05	0.00107	CcSEcCtD
Toremifene—Dyspnoea—Fluorouracil—pancreatic cancer	6.42e-05	0.00107	CcSEcCtD
Toremifene—Mental disorder—Docetaxel—pancreatic cancer	6.41e-05	0.00106	CcSEcCtD
Toremifene—Malnutrition—Docetaxel—pancreatic cancer	6.37e-05	0.00106	CcSEcCtD
Toremifene—Decreased appetite—Gemcitabine—pancreatic cancer	6.37e-05	0.00106	CcSEcCtD
Toremifene—Nausea—Tamoxifen—pancreatic cancer	6.33e-05	0.00105	CcSEcCtD
Toremifene—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	6.32e-05	0.00105	CcSEcCtD
Toremifene—Fatigue—Gemcitabine—pancreatic cancer	6.32e-05	0.00105	CcSEcCtD
Toremifene—Pain—Gemcitabine—pancreatic cancer	6.26e-05	0.00104	CcSEcCtD
Toremifene—Constipation—Gemcitabine—pancreatic cancer	6.26e-05	0.00104	CcSEcCtD
Toremifene—Nausea—Erlotinib—pancreatic cancer	6.26e-05	0.00104	CcSEcCtD
Toremifene—Decreased appetite—Fluorouracil—pancreatic cancer	6.26e-05	0.00104	CcSEcCtD
Toremifene—Mood swings—Doxorubicin—pancreatic cancer	6.25e-05	0.00104	CcSEcCtD
Toremifene—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	6.22e-05	0.00103	CcSEcCtD
Toremifene—Ataxia—Doxorubicin—pancreatic cancer	6.21e-05	0.00103	CcSEcCtD
Toremifene—Back pain—Docetaxel—pancreatic cancer	6.16e-05	0.00102	CcSEcCtD
Toremifene—Pain—Fluorouracil—pancreatic cancer	6.16e-05	0.00102	CcSEcCtD
Toremifene—Liver function test abnormal—Doxorubicin—pancreatic cancer	6.09e-05	0.00101	CcSEcCtD
Toremifene—Dizziness—Sunitinib—pancreatic cancer	6.04e-05	0.001	CcSEcCtD
Toremifene—Angina pectoris—Epirubicin—pancreatic cancer	6.01e-05	0.000997	CcSEcCtD
Toremifene—Breast disorder—Doxorubicin—pancreatic cancer	5.97e-05	0.00099	CcSEcCtD
Toremifene—Vomiting—Sunitinib—pancreatic cancer	5.81e-05	0.000964	CcSEcCtD
Toremifene—Rash—Sunitinib—pancreatic cancer	5.76e-05	0.000956	CcSEcCtD
Toremifene—Dermatitis—Sunitinib—pancreatic cancer	5.75e-05	0.000955	CcSEcCtD
Toremifene—Headache—Sunitinib—pancreatic cancer	5.72e-05	0.00095	CcSEcCtD
Toremifene—Leukopenia—Docetaxel—pancreatic cancer	5.7e-05	0.000947	CcSEcCtD
Toremifene—Weight increased—Epirubicin—pancreatic cancer	5.61e-05	0.000932	CcSEcCtD
Toremifene—Angina pectoris—Doxorubicin—pancreatic cancer	5.56e-05	0.000923	CcSEcCtD
Toremifene—Chest pain—Docetaxel—pancreatic cancer	5.42e-05	0.0009	CcSEcCtD
Toremifene—Nausea—Sunitinib—pancreatic cancer	5.42e-05	0.0009	CcSEcCtD
Toremifene—Asthenia—Irinotecan—pancreatic cancer	5.4e-05	0.000896	CcSEcCtD
Toremifene—Neuropathy peripheral—Epirubicin—pancreatic cancer	5.39e-05	0.000895	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	5.39e-05	0.000894	CcSEcCtD
Toremifene—Jaundice—Epirubicin—pancreatic cancer	5.36e-05	0.00089	CcSEcCtD
Toremifene—Sweating—Epirubicin—pancreatic cancer	5.27e-05	0.000875	CcSEcCtD
Toremifene—Asthenia—Gemcitabine—pancreatic cancer	5.26e-05	0.000873	CcSEcCtD
Toremifene—Hepatobiliary disease—Epirubicin—pancreatic cancer	5.2e-05	0.000863	CcSEcCtD
Toremifene—Oedema—Docetaxel—pancreatic cancer	5.2e-05	0.000863	CcSEcCtD
Toremifene—Weight increased—Doxorubicin—pancreatic cancer	5.19e-05	0.000862	CcSEcCtD
Toremifene—Pruritus—Gemcitabine—pancreatic cancer	5.18e-05	0.000861	CcSEcCtD
Toremifene—Nervous system disorder—Docetaxel—pancreatic cancer	5.1e-05	0.000846	CcSEcCtD
Toremifene—Pruritus—Fluorouracil—pancreatic cancer	5.1e-05	0.000846	CcSEcCtD
Toremifene—Thrombocytopenia—Docetaxel—pancreatic cancer	5.09e-05	0.000845	CcSEcCtD
Toremifene—Skin disorder—Docetaxel—pancreatic cancer	5.05e-05	0.000838	CcSEcCtD
Toremifene—Neuropathy peripheral—Doxorubicin—pancreatic cancer	4.99e-05	0.000828	CcSEcCtD
Toremifene—Dizziness—Irinotecan—pancreatic cancer	4.97e-05	0.000826	CcSEcCtD
Toremifene—Jaundice—Doxorubicin—pancreatic cancer	4.96e-05	0.000823	CcSEcCtD
Toremifene—Anorexia—Docetaxel—pancreatic cancer	4.96e-05	0.000823	CcSEcCtD
Toremifene—Sweating—Doxorubicin—pancreatic cancer	4.88e-05	0.00081	CcSEcCtD
Toremifene—Hepatobiliary disease—Doxorubicin—pancreatic cancer	4.81e-05	0.000799	CcSEcCtD
Toremifene—Vomiting—Irinotecan—pancreatic cancer	4.78e-05	0.000794	CcSEcCtD
Toremifene—Dizziness—Fluorouracil—pancreatic cancer	4.76e-05	0.000791	CcSEcCtD
Toremifene—Visual impairment—Epirubicin—pancreatic cancer	4.76e-05	0.00079	CcSEcCtD
Toremifene—Rash—Irinotecan—pancreatic cancer	4.74e-05	0.000787	CcSEcCtD
Toremifene—Dermatitis—Irinotecan—pancreatic cancer	4.74e-05	0.000787	CcSEcCtD
Toremifene—Headache—Irinotecan—pancreatic cancer	4.71e-05	0.000782	CcSEcCtD
Toremifene—Insomnia—Docetaxel—pancreatic cancer	4.7e-05	0.000781	CcSEcCtD
Toremifene—Vomiting—Gemcitabine—pancreatic cancer	4.66e-05	0.000773	CcSEcCtD
Toremifene—Dyspnoea—Docetaxel—pancreatic cancer	4.64e-05	0.00077	CcSEcCtD
Toremifene—Rash—Gemcitabine—pancreatic cancer	4.62e-05	0.000767	CcSEcCtD
Toremifene—Dermatitis—Gemcitabine—pancreatic cancer	4.61e-05	0.000766	CcSEcCtD
Toremifene—Eye disorder—Epirubicin—pancreatic cancer	4.61e-05	0.000766	CcSEcCtD
Toremifene—Headache—Gemcitabine—pancreatic cancer	4.59e-05	0.000762	CcSEcCtD
Toremifene—Vomiting—Fluorouracil—pancreatic cancer	4.58e-05	0.00076	CcSEcCtD
Toremifene—Rash—Fluorouracil—pancreatic cancer	4.54e-05	0.000754	CcSEcCtD
Toremifene—Dermatitis—Fluorouracil—pancreatic cancer	4.54e-05	0.000753	CcSEcCtD
Toremifene—Decreased appetite—Docetaxel—pancreatic cancer	4.52e-05	0.00075	CcSEcCtD
Toremifene—Headache—Fluorouracil—pancreatic cancer	4.51e-05	0.000749	CcSEcCtD
Toremifene—Gastrointestinal disorder—Docetaxel—pancreatic cancer	4.49e-05	0.000745	CcSEcCtD
Toremifene—Fatigue—Docetaxel—pancreatic cancer	4.48e-05	0.000744	CcSEcCtD
Toremifene—Angiopathy—Epirubicin—pancreatic cancer	4.48e-05	0.000743	CcSEcCtD
Toremifene—Nausea—Irinotecan—pancreatic cancer	4.47e-05	0.000742	CcSEcCtD
Toremifene—Mediastinal disorder—Epirubicin—pancreatic cancer	4.45e-05	0.000739	CcSEcCtD
Toremifene—Pain—Docetaxel—pancreatic cancer	4.45e-05	0.000738	CcSEcCtD
Toremifene—Constipation—Docetaxel—pancreatic cancer	4.45e-05	0.000738	CcSEcCtD
Toremifene—Chills—Epirubicin—pancreatic cancer	4.43e-05	0.000735	CcSEcCtD
Toremifene—Arrhythmia—Epirubicin—pancreatic cancer	4.41e-05	0.000732	CcSEcCtD
Toremifene—Visual impairment—Doxorubicin—pancreatic cancer	4.4e-05	0.000731	CcSEcCtD
Toremifene—Alopecia—Epirubicin—pancreatic cancer	4.36e-05	0.000724	CcSEcCtD
Toremifene—Nausea—Gemcitabine—pancreatic cancer	4.35e-05	0.000722	CcSEcCtD
Toremifene—Mental disorder—Epirubicin—pancreatic cancer	4.32e-05	0.000718	CcSEcCtD
Toremifene—Malnutrition—Epirubicin—pancreatic cancer	4.3e-05	0.000713	CcSEcCtD
Toremifene—Nausea—Fluorouracil—pancreatic cancer	4.28e-05	0.00071	CcSEcCtD
Toremifene—Eye disorder—Doxorubicin—pancreatic cancer	4.27e-05	0.000709	CcSEcCtD
Toremifene—Back pain—Epirubicin—pancreatic cancer	4.16e-05	0.00069	CcSEcCtD
Toremifene—Angiopathy—Doxorubicin—pancreatic cancer	4.14e-05	0.000688	CcSEcCtD
Toremifene—Mediastinal disorder—Doxorubicin—pancreatic cancer	4.12e-05	0.000683	CcSEcCtD
Toremifene—Chills—Doxorubicin—pancreatic cancer	4.1e-05	0.00068	CcSEcCtD
Toremifene—Arrhythmia—Doxorubicin—pancreatic cancer	4.08e-05	0.000677	CcSEcCtD
Toremifene—Vision blurred—Epirubicin—pancreatic cancer	4.05e-05	0.000672	CcSEcCtD
Toremifene—Alopecia—Doxorubicin—pancreatic cancer	4.04e-05	0.00067	CcSEcCtD
Toremifene—Mental disorder—Doxorubicin—pancreatic cancer	4e-05	0.000664	CcSEcCtD
Toremifene—Malnutrition—Doxorubicin—pancreatic cancer	3.98e-05	0.00066	CcSEcCtD
Toremifene—Vertigo—Epirubicin—pancreatic cancer	3.86e-05	0.000641	CcSEcCtD
Toremifene—Leukopenia—Epirubicin—pancreatic cancer	3.85e-05	0.000639	CcSEcCtD
Toremifene—Back pain—Doxorubicin—pancreatic cancer	3.85e-05	0.000638	CcSEcCtD
Toremifene—Vision blurred—Doxorubicin—pancreatic cancer	3.75e-05	0.000622	CcSEcCtD
Toremifene—Asthenia—Docetaxel—pancreatic cancer	3.73e-05	0.000619	CcSEcCtD
Toremifene—Pruritus—Docetaxel—pancreatic cancer	3.68e-05	0.000611	CcSEcCtD
Toremifene—Chest pain—Epirubicin—pancreatic cancer	3.66e-05	0.000607	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	3.63e-05	0.000603	CcSEcCtD
Toremifene—Vertigo—Doxorubicin—pancreatic cancer	3.57e-05	0.000593	CcSEcCtD
Toremifene—Leukopenia—Doxorubicin—pancreatic cancer	3.56e-05	0.000591	CcSEcCtD
Toremifene—Oedema—Epirubicin—pancreatic cancer	3.51e-05	0.000582	CcSEcCtD
Toremifene—Nervous system disorder—Epirubicin—pancreatic cancer	3.44e-05	0.000571	CcSEcCtD
Toremifene—Dizziness—Docetaxel—pancreatic cancer	3.44e-05	0.000571	CcSEcCtD
Toremifene—Thrombocytopenia—Epirubicin—pancreatic cancer	3.43e-05	0.00057	CcSEcCtD
Toremifene—Skin disorder—Epirubicin—pancreatic cancer	3.41e-05	0.000566	CcSEcCtD
Toremifene—Hyperhidrosis—Epirubicin—pancreatic cancer	3.39e-05	0.000563	CcSEcCtD
Toremifene—Chest pain—Doxorubicin—pancreatic cancer	3.38e-05	0.000562	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	3.36e-05	0.000558	CcSEcCtD
Toremifene—Anorexia—Epirubicin—pancreatic cancer	3.34e-05	0.000555	CcSEcCtD
Toremifene—Vomiting—Docetaxel—pancreatic cancer	3.31e-05	0.000549	CcSEcCtD
Toremifene—Rash—Docetaxel—pancreatic cancer	3.28e-05	0.000544	CcSEcCtD
Toremifene—Dermatitis—Docetaxel—pancreatic cancer	3.28e-05	0.000544	CcSEcCtD
Toremifene—Headache—Docetaxel—pancreatic cancer	3.26e-05	0.000541	CcSEcCtD
Toremifene—Oedema—Doxorubicin—pancreatic cancer	3.24e-05	0.000539	CcSEcCtD
Toremifene—Nervous system disorder—Doxorubicin—pancreatic cancer	3.18e-05	0.000528	CcSEcCtD
Toremifene—Thrombocytopenia—Doxorubicin—pancreatic cancer	3.18e-05	0.000527	CcSEcCtD
Toremifene—Insomnia—Epirubicin—pancreatic cancer	3.17e-05	0.000527	CcSEcCtD
Toremifene—Skin disorder—Doxorubicin—pancreatic cancer	3.15e-05	0.000523	CcSEcCtD
Toremifene—Hyperhidrosis—Doxorubicin—pancreatic cancer	3.14e-05	0.000521	CcSEcCtD
Toremifene—Dyspnoea—Epirubicin—pancreatic cancer	3.13e-05	0.000519	CcSEcCtD
Toremifene—Anorexia—Doxorubicin—pancreatic cancer	3.09e-05	0.000513	CcSEcCtD
Toremifene—Nausea—Docetaxel—pancreatic cancer	3.09e-05	0.000513	CcSEcCtD
Toremifene—Decreased appetite—Epirubicin—pancreatic cancer	3.05e-05	0.000506	CcSEcCtD
Toremifene—Gastrointestinal disorder—Epirubicin—pancreatic cancer	3.03e-05	0.000503	CcSEcCtD
Toremifene—Fatigue—Epirubicin—pancreatic cancer	3.02e-05	0.000502	CcSEcCtD
Toremifene—Pain—Epirubicin—pancreatic cancer	3e-05	0.000498	CcSEcCtD
Toremifene—Constipation—Epirubicin—pancreatic cancer	3e-05	0.000498	CcSEcCtD
Toremifene—Insomnia—Doxorubicin—pancreatic cancer	2.93e-05	0.000487	CcSEcCtD
Toremifene—Dyspnoea—Doxorubicin—pancreatic cancer	2.89e-05	0.00048	CcSEcCtD
Toremifene—Decreased appetite—Doxorubicin—pancreatic cancer	2.82e-05	0.000468	CcSEcCtD
Toremifene—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	2.8e-05	0.000465	CcSEcCtD
Toremifene—Fatigue—Doxorubicin—pancreatic cancer	2.8e-05	0.000464	CcSEcCtD
Toremifene—Pain—Doxorubicin—pancreatic cancer	2.77e-05	0.000461	CcSEcCtD
Toremifene—Constipation—Doxorubicin—pancreatic cancer	2.77e-05	0.000461	CcSEcCtD
Toremifene—Asthenia—Epirubicin—pancreatic cancer	2.52e-05	0.000418	CcSEcCtD
Toremifene—Pruritus—Epirubicin—pancreatic cancer	2.48e-05	0.000412	CcSEcCtD
Toremifene—Asthenia—Doxorubicin—pancreatic cancer	2.33e-05	0.000386	CcSEcCtD
Toremifene—Dizziness—Epirubicin—pancreatic cancer	2.32e-05	0.000385	CcSEcCtD
Toremifene—Pruritus—Doxorubicin—pancreatic cancer	2.3e-05	0.000381	CcSEcCtD
Toremifene—Vomiting—Epirubicin—pancreatic cancer	2.23e-05	0.00037	CcSEcCtD
Toremifene—Rash—Epirubicin—pancreatic cancer	2.21e-05	0.000367	CcSEcCtD
Toremifene—Dermatitis—Epirubicin—pancreatic cancer	2.21e-05	0.000367	CcSEcCtD
Toremifene—Headache—Epirubicin—pancreatic cancer	2.2e-05	0.000365	CcSEcCtD
Toremifene—Dizziness—Doxorubicin—pancreatic cancer	2.15e-05	0.000356	CcSEcCtD
Toremifene—Nausea—Epirubicin—pancreatic cancer	2.08e-05	0.000346	CcSEcCtD
Toremifene—Vomiting—Doxorubicin—pancreatic cancer	2.06e-05	0.000343	CcSEcCtD
Toremifene—Rash—Doxorubicin—pancreatic cancer	2.05e-05	0.00034	CcSEcCtD
Toremifene—Dermatitis—Doxorubicin—pancreatic cancer	2.04e-05	0.000339	CcSEcCtD
Toremifene—Headache—Doxorubicin—pancreatic cancer	2.03e-05	0.000337	CcSEcCtD
Toremifene—Nausea—Doxorubicin—pancreatic cancer	1.93e-05	0.00032	CcSEcCtD
Toremifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	1.62e-05	0.00152	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	1.59e-05	0.00149	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	1.57e-05	0.00147	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	1.55e-05	0.00145	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	1.54e-05	0.00144	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	1.52e-05	0.00142	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	1.52e-05	0.00142	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—AKT1—pancreatic cancer	1.51e-05	0.00141	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	1.5e-05	0.0014	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—PTEN—pancreatic cancer	1.49e-05	0.00139	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	1.48e-05	0.00138	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	1.48e-05	0.00138	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	1.46e-05	0.00137	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	1.42e-05	0.00133	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	1.42e-05	0.00133	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	1.42e-05	0.00133	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	1.42e-05	0.00133	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	1.39e-05	0.0013	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	1.38e-05	0.00129	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	1.36e-05	0.00127	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	1.36e-05	0.00127	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	1.35e-05	0.00127	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	1.35e-05	0.00126	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	1.33e-05	0.00125	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	1.33e-05	0.00125	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—NRAS—pancreatic cancer	1.33e-05	0.00124	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	1.32e-05	0.00124	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—SMAD4—pancreatic cancer	1.29e-05	0.00121	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	1.29e-05	0.0012	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	1.27e-05	0.00119	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	1.27e-05	0.00119	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	1.27e-05	0.00119	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	1.26e-05	0.00118	CbGpPWpGaD
Toremifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—pancreatic cancer	1.26e-05	0.00118	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	1.24e-05	0.00116	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.24e-05	0.00116	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PRLHR—pancreatic cancer	1.23e-05	0.00115	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	1.22e-05	0.00114	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—EGFR—pancreatic cancer	1.21e-05	0.00113	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	1.2e-05	0.00112	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ZNRF3—pancreatic cancer	1.16e-05	0.00108	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ACVR1B—pancreatic cancer	1.16e-05	0.00108	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.15e-05	0.00108	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	1.15e-05	0.00108	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—KRAS—pancreatic cancer	1.14e-05	0.00107	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.12e-05	0.00105	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	1.1e-05	0.00103	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	1.07e-05	0.001	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—PIK3CA—pancreatic cancer	1.05e-05	0.000983	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SSTR3—pancreatic cancer	1.05e-05	0.000981	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—DTX1—pancreatic cancer	1.05e-05	0.000981	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.03e-05	0.000965	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—TNF—pancreatic cancer	1.03e-05	0.000964	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.03e-05	0.000963	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MEN1—pancreatic cancer	1.02e-05	0.000958	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	1.02e-05	0.000958	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	1.02e-05	0.000956	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.01e-05	0.000944	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SSTR1—pancreatic cancer	1.01e-05	0.000941	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PPY—pancreatic cancer	9.86e-06	0.000922	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	9.8e-06	0.000917	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—HRAS—pancreatic cancer	9.72e-06	0.00091	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—NOTCH4—pancreatic cancer	9.71e-06	0.000909	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SSTR2—pancreatic cancer	9.67e-06	0.000905	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	9.6e-06	0.000899	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	9.53e-06	0.000892	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—NOTCH1—pancreatic cancer	9.52e-06	0.000891	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCKBR—pancreatic cancer	9.34e-06	0.000875	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—HSPA1B—pancreatic cancer	9.26e-06	0.000867	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PRSS1—pancreatic cancer	9.18e-06	0.000859	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—PPARG—pancreatic cancer	8.98e-06	0.000841	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	8.93e-06	0.000836	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	8.85e-06	0.000828	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—DTX4—pancreatic cancer	8.78e-06	0.000822	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GLI1—pancreatic cancer	8.78e-06	0.000822	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	8.75e-06	0.000819	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	8.63e-06	0.000808	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—AKT1—pancreatic cancer	8.58e-06	0.000803	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NRP1—pancreatic cancer	8.55e-06	0.0008	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PPP2R5B—pancreatic cancer	8.55e-06	0.0008	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	8.47e-06	0.000792	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—EZH2—pancreatic cancer	8.43e-06	0.000789	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—NOTCH3—pancreatic cancer	8.25e-06	0.000773	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HEY2—pancreatic cancer	8.23e-06	0.00077	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GAST—pancreatic cancer	8.03e-06	0.000752	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ARG2—pancreatic cancer	7.96e-06	0.000745	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—HSPA1A—pancreatic cancer	7.82e-06	0.000732	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SCT—pancreatic cancer	7.62e-06	0.000713	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HEY1—pancreatic cancer	7.62e-06	0.000713	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	7.53e-06	0.000704	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PRSS1—pancreatic cancer	7.33e-06	0.000686	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCK—pancreatic cancer	7.27e-06	0.00068	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	7.15e-06	0.000669	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CNR2—pancreatic cancer	7.08e-06	0.000663	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GLP1R—pancreatic cancer	7.08e-06	0.000663	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	6.99e-06	0.000654	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCKAR—pancreatic cancer	6.97e-06	0.000652	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—TYMP—pancreatic cancer	6.96e-06	0.000651	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	6.8e-06	0.000637	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—JAG2—pancreatic cancer	6.76e-06	0.000632	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	6.73e-06	0.00063	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MEN1—pancreatic cancer	6.66e-06	0.000623	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	6.56e-06	0.000614	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ARG2—pancreatic cancer	6.36e-06	0.000595	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SHH—pancreatic cancer	6.35e-06	0.000594	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NOTCH4—pancreatic cancer	6.31e-06	0.000591	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IAPP—pancreatic cancer	6.27e-06	0.000587	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—SMAD4—pancreatic cancer	6.22e-06	0.000582	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	6.09e-06	0.00057	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTHLH—pancreatic cancer	6.02e-06	0.000564	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTCH1—pancreatic cancer	6.02e-06	0.000564	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	5.93e-06	0.000555	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PRSS1—pancreatic cancer	5.86e-06	0.000548	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.74e-06	0.000538	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GLP1R—pancreatic cancer	5.61e-06	0.000525	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—TYMP—pancreatic cancer	5.56e-06	0.00052	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—DPYD—pancreatic cancer	5.52e-06	0.000517	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SST—pancreatic cancer	5.51e-06	0.000515	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	5.45e-06	0.000511	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	5.44e-06	0.000509	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—JAG1—pancreatic cancer	5.39e-06	0.000504	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NOTCH3—pancreatic cancer	5.37e-06	0.000502	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	5.34e-06	0.000499	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—SLC2A2—pancreatic cancer	5.24e-06	0.00049	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.18e-06	0.000485	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—MYC—pancreatic cancer	5.12e-06	0.000479	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CNR1—pancreatic cancer	5.08e-06	0.000476	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	5.08e-06	0.000476	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ARG2—pancreatic cancer	5.08e-06	0.000475	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	5.04e-06	0.000472	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5e-06	0.000468	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GCG—pancreatic cancer	4.91e-06	0.000459	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AGTR1—pancreatic cancer	4.68e-06	0.000438	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	4.63e-06	0.000433	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—STK11—pancreatic cancer	4.61e-06	0.000432	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—NOTCH1—pancreatic cancer	4.58e-06	0.000429	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.56e-06	0.000426	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PRSS1—pancreatic cancer	4.52e-06	0.000423	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GLP1R—pancreatic cancer	4.48e-06	0.000419	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	4.48e-06	0.000419	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—TYMP—pancreatic cancer	4.44e-06	0.000415	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—DPYD—pancreatic cancer	4.41e-06	0.000413	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PPARG—pancreatic cancer	4.32e-06	0.000405	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SLC2A2—pancreatic cancer	4.18e-06	0.000392	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CD44—pancreatic cancer	4.06e-06	0.00038	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SMAD4—pancreatic cancer	4.04e-06	0.000378	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.97e-06	0.000372	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HES1—pancreatic cancer	3.95e-06	0.000369	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.93e-06	0.000368	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ARG2—pancreatic cancer	3.92e-06	0.000367	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GCG—pancreatic cancer	3.89e-06	0.000364	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	3.78e-06	0.000354	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.66e-06	0.000343	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—STK11—pancreatic cancer	3.66e-06	0.000342	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GLP1R—pancreatic cancer	3.58e-06	0.000335	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—DPYD—pancreatic cancer	3.52e-06	0.000329	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TERT—pancreatic cancer	3.46e-06	0.000324	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.43e-06	0.000321	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—TYMP—pancreatic cancer	3.42e-06	0.000321	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	3.34e-06	0.000313	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HIF1A—pancreatic cancer	3.31e-06	0.00031	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.3e-06	0.000309	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TSC2—pancreatic cancer	3.3e-06	0.000309	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CD44—pancreatic cancer	3.24e-06	0.000303	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APOE—pancreatic cancer	3.23e-06	0.000302	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.19e-06	0.000299	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KDR—pancreatic cancer	3.16e-06	0.000296	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—TYMS—pancreatic cancer	3.14e-06	0.000294	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GCG—pancreatic cancer	3.11e-06	0.000291	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NFKBIA—pancreatic cancer	3.01e-06	0.000282	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NOTCH1—pancreatic cancer	2.98e-06	0.000279	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—STK11—pancreatic cancer	2.92e-06	0.000273	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CG—pancreatic cancer	2.91e-06	0.000273	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.91e-06	0.000272	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EGF—pancreatic cancer	2.88e-06	0.00027	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GLP1R—pancreatic cancer	2.76e-06	0.000258	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—DPYD—pancreatic cancer	2.72e-06	0.000254	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CD44—pancreatic cancer	2.59e-06	0.000242	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	2.58e-06	0.000241	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CD—pancreatic cancer	2.56e-06	0.00024	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APOE—pancreatic cancer	2.56e-06	0.000239	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.53e-06	0.000237	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—TYMS—pancreatic cancer	2.51e-06	0.000235	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.51e-06	0.000235	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GCG—pancreatic cancer	2.48e-06	0.000232	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MYC—pancreatic cancer	2.47e-06	0.000231	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.42e-06	0.000227	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—STK11—pancreatic cancer	2.33e-06	0.000218	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	2.31e-06	0.000216	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CB—pancreatic cancer	2.23e-06	0.000209	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPARG—pancreatic cancer	2.23e-06	0.000209	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.19e-06	0.000205	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CXCL8—pancreatic cancer	2.15e-06	0.000201	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CASP3—pancreatic cancer	2.05e-06	0.000192	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOE—pancreatic cancer	2.04e-06	0.000191	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	2.03e-06	0.00019	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—TYMS—pancreatic cancer	2.01e-06	0.000188	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCND1—pancreatic cancer	2e-06	0.000187	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CD44—pancreatic cancer	2e-06	0.000187	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CTNNB1—pancreatic cancer	1.98e-06	0.000185	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MMP9—pancreatic cancer	1.94e-06	0.000182	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTEN—pancreatic cancer	1.93e-06	0.000181	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GCG—pancreatic cancer	1.91e-06	0.000179	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CG—pancreatic cancer	1.84e-06	0.000173	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—STK11—pancreatic cancer	1.8e-06	0.000168	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SRC—pancreatic cancer	1.79e-06	0.000167	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPARG—pancreatic cancer	1.78e-06	0.000167	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	1.77e-06	0.000166	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTGS2—pancreatic cancer	1.75e-06	0.000164	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VEGFA—pancreatic cancer	1.74e-06	0.000163	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—STAT3—pancreatic cancer	1.73e-06	0.000161	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NRAS—pancreatic cancer	1.72e-06	0.000161	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—AKT1—pancreatic cancer	1.71e-06	0.00016	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOE—pancreatic cancer	1.63e-06	0.000153	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CD—pancreatic cancer	1.62e-06	0.000152	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MYC—pancreatic cancer	1.6e-06	0.00015	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TGFB1—pancreatic cancer	1.6e-06	0.00015	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EGFR—pancreatic cancer	1.57e-06	0.000147	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.55e-06	0.000145	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.54e-06	0.000144	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTEN—pancreatic cancer	1.53e-06	0.000143	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KRAS—pancreatic cancer	1.48e-06	0.000139	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	1.47e-06	0.000138	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.42e-06	0.000133	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.41e-06	0.000132	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.4e-06	0.000131	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CA—pancreatic cancer	1.36e-06	0.000127	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TP53—pancreatic cancer	1.32e-06	0.000123	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	1.29e-06	0.000121	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HRAS—pancreatic cancer	1.26e-06	0.000118	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOE—pancreatic cancer	1.26e-06	0.000118	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTEN—pancreatic cancer	1.22e-06	0.000114	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.14e-06	0.000106	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.13e-06	0.000106	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTGS2—pancreatic cancer	1.12e-06	0.000105	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT1—pancreatic cancer	1.11e-06	0.000104	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.1e-06	0.000103	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	1.08e-06	0.000101	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	9.98e-07	9.35e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTEN—pancreatic cancer	9.74e-07	9.12e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AKT1—pancreatic cancer	8.81e-07	8.24e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	8.7e-07	8.15e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTGS2—pancreatic cancer	8.62e-07	8.07e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CA—pancreatic cancer	8.61e-07	8.06e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTEN—pancreatic cancer	7.52e-07	7.04e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AKT1—pancreatic cancer	7.03e-07	6.58e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	6.87e-07	6.43e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AKT1—pancreatic cancer	5.62e-07	5.26e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	5.31e-07	4.97e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKT1—pancreatic cancer	4.33e-07	4.06e-05	CbGpPWpGaD
